Martin Fan Analyst Performance

Martin Fan is a Vice President, Equity Research with over a decade of experience in drug discovery and analytics within the biotechnology sector. Before joining equity research, he held scientific and business development roles across both industry and academic institutions, with therapeutic focuses in oncology, vaccines and infectious diseases, and autoimmunity. His experience spans the bench to the boardroom—having worked as a bench scientist and later in business development—giving him a unique perspective on the biotech landscape. Prior to transitioning into research, Martin also worked in business consulting, where he specialized in translating complex clinical and scientific data for both specialist and generalist investors. Martin earned his B.S. in Biochemistry from Washington University in St. Louis and holds a Ph.D. in Immunology from Harvard University.